Treatment of patients with essential tremor (Q34025450)

30 July 2017

1 reference

title

Treatment of patients with essential tremor (English)

1 reference

30 July 2017

0 references

1

Günther Deuschl

0 references

author name string

Jan Raethjen

series ordinal

2

1 reference

30 July 2017

Helge Hellriegel

series ordinal

3

1 reference

30 July 2017

Rodger Elble

series ordinal

4

1 reference

30 July 2017

language of work or name

1 reference

1 February 2011

1 reference

30 July 2017

1 reference

30 July 2017

10

1 reference

30 July 2017

2

1 reference

30 July 2017

148-161

1 reference

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Clinical characteristics of essential tremor in Mersin, Turkey--a population-based door-to-door study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Correlates of functional disability in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Low prevalence of hearing aid use among older adults with hearing loss: the Epidemiology of Hearing Loss Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Observations on essential (heredofamial) tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Essential tremor--neurodegenerative or nondegenerative disease towards a working definition of ET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

An update on essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

The Washington Heights-Inwood Genetic Study of Essential Tremor: Methodologic Issues in Essential-Tremor Research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Essential tremor: an overdiagnosed condition?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Intention tremor in essential tremor: Prevalence and association with disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Intention tremor of the head in patients with essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

The gait disorder of advanced essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gait abnormality in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Eyeblink conditioning is impaired in subjects with essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Impaired rhythm generation in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Personality in essential tremor: further evidence of non-motor manifestations of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Cognitive deficits in patients with essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quality of life and personality in essential tremor patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Non-motor manifestations in essential tremor: use of a validated instrument to evaluate a wide spectrum of symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Neuropathological changes in essential tremor: 33 cases compared with 21 controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Hearing impairment in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Faster rate of cognitive decline in essential tremor cases than controls: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Risk of incident dementia in essential tremor: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Assessing tremor severity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Is essential tremor benign?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Levetiracetam is not effective for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Assessing the impact of essential tremor on upper limb function.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Double-blind controlled study of primidone in essential tremor: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Primidone in essential tremor of the hands and head: a double blind controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Double-blind comparison of primidone and phenobarbital in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Acute tolerance to the tremorolytic effect of primidone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Randomized trial comparing primidone initiation schedules for treating essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Efficacy of primidone in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Acute and chronic effects of propranolol and primidone in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Phenobarbital and propranolol in essential tremor: A double-blind controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Propranolol and propranolol-LA in essential tremor: a double blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Treatment of benign essential tremor with propranolol. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

beta-Adrenoreceptor antagonists in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Atenolol vs. propranolol in essential tremor. A controlled, quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Efficacy of Chronic Propranolol Therapy in Action Tremors of the Familial, Senile or Essential Varieties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Propranolol treatment of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Effect of propranolol on essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Effect of a single oral dose of propranolol on essential tremor: A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Essential tremor: Treatment with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Relationship between plasma propranolol concentration and relief of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Dose-response relationship of propranolol in the treatment of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Efficacy of alprazolam for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Topiramate in essential tremor: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Nadolol in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Zonisamide for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Zonisamide for essential tremor: an evaluator-blinded study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Tiagabine for essential tremor: an open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Extensive S aureus spinal epidural empyema

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Pilot trial of 1-octanol in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

The effect of levetiracetam on essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

An open-label pilot study of levetiracetam for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Levetiracetam for the treatment of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Carisbamate in essential tremor: brief report of a proof of concept study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Deep brain stimulation for essential tremor: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation for management of essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term evaluation of deep brain stimulation of the thalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Multicentre European study of thalamic stimulation in essential tremor: a six year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term results of thalamic deep brain stimulation for essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thirty days complication rate following surgery performed for deep-brain-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Further definition of the subthalamic target for arrest of tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Long-term results of stereotaxy in the treatment of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Functional neuroanatomy of the target area for the treatment of pathological tremor: an electrophysiological approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Deep brain stimulation of subthalamic area for severe proximal tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Complications and side effects of deep brain stimulation in the posterior subthalamic area.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Bilateral stimulation of the caudal zona incerta nucleus for tremor control

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Electrical stimulation of the posterior subthalamic area for the treatment of intractable proximal tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Subthalamic stimulation for essential tremor. Short- and long-term results and critical target area

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gamma knife thalamotomy for disabling tremor: a blinded evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gamma knife thalamotomy for movement disorders: evaluation of the thalamic lesion and clinical results.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gamma Knife thalamotomy for treatment of essential tremor: long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Gamma Knife thalamotomy for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Trunk and head tremor as isolated manifestations of dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Isolated head tremor: part of the clinical spectrum of essential tremor? Data from population-based and clinic-based case samples

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Clinical characteristics of essential voice tremor: a study of 34 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Propranolol therapy for essential tremor of the head

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quantitative comparison of barbiturates in essential hand and head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Botulinum toxin treatment of essential head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic stimulation for the treatment of midline tremors in essential tremor patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation: comparison between unilateral and bilateral placement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Essential voice tremor: treatment with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Double-blind controlled study of methazolamide in the treatment of essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Botulinum toxin type A for treating voice tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Reduction in voice tremor under thalamic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Quantification of essential tremor in writing and drawing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Clinically deployable Kinesia technology for automated tremor assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970322-7

7 January 2021

10.1016/S1474-4422(10)70322-7

Identifiers

DOI

1 reference

30 July 2017

1 reference